DrugPatentWatch Database Preview
Drugs in Development Information for AZD5718
» See Plans and Pricing
What is the drug development status for AZD5718?
AZD5718 is an investigational drug.
There have been 11 clinical trials for AZD5718.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 5th 2020.
The most common disease conditions in clinical trials are Coronary Artery Disease, Myocardial Ischemia, and Coronary Disease. The leading clinical trial sponsors are AstraZeneca, Parexel, and National University Heart Centre, Singapore.
There is one US patent protecting this investigational drug and thirty-five international patents.
Summary for AZD5718
| US Patents | 1 |
| International Patents | 35 |
| US Patent Applications | 3 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2020-10-05) |
| Vendors | 1 |
Recent Clinical Trials for AZD5718
| Title | Sponsor | Phase |
|---|---|---|
| PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE | AstraZeneca | Phase 2 |
| PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE | National University Heart Centre, Singapore | Phase 2 |
| A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease | George Clinical Pty Ltd | Phase 2 |
Clinical Trial Summary for AZD5718
Top disease conditions for AZD5718
Top clinical trial sponsors for AZD5718
US Patents for AZD5718
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD5718 | Start Trial | Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors | ASTRAZENECA AB (Sodertalje, SE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD5718
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD5718 | Argentina | AR104512 | 2035-05-04 | Start Trial |
| AZD5718 | Australia | AU2016258874 | 2035-05-04 | Start Trial |
| AZD5718 | Brazil | BR112017022757 | 2035-05-04 | Start Trial |
| AZD5718 | Canada | CA2983668 | 2035-05-04 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
